1,171 results on '"Haynes, Kevin"'
Search Results
152. Practical challenges in the conduct of pragmatic trials embedded in health plans: Lessons of IMPACT-AFib, an FDA-Catalyst trial
153. Concomitant Filled Prescriptions of Oxymorphone or Oxycodone with CYP3A Inhibitors and Inducers
154. Rationale and Design of the Aspirin Dosing—A Patient-Centric Trial Assessing Benefits and Long-term Effectiveness (ADAPTABLE) Trial
155. Incidence of Serious Infections and Design of Utilization and Safety Studies for Biologic and Biosimilar Surveillance
156. The association between allopurinol use and urologic malignancies: A nested case-control study.
157. Role of health plan administrative claims data in participant recruitment for pragmatic clinical trials: An Aspirin Dosing: A Patient-centric Trial Assessing Benefits and Long-term Effectiveness (ADAPTABLE) example
158. Prescribing cascades in persons with Alzheimer’s disease: engaging patients, caregivers, and providers in a qualitative evaluation of print educational materials
159. Diagnosed prevalence of Alzheimer's disease and related dementias in Medicare Advantage plans
160. Linking electronic health data in pharmacoepidemiology: Appropriateness and feasibility
161. Validity of The Health Improvement Network (THIN) for epidemiologic studies of hepatitis C virus infection
162. Cancer incidence in The Health Improvement Network
163. Increased risk of digoxin toxicity following hospitalization†
164. Does an Increase in Serum Creatinine after Starting ACE Inhibitors Influence Their Discontinuation: 632.
165. Recording of Pancreatic, Colorectal, and Lung Cancer Incidence in the Health Improvement Network (THIN): 086.
166. Additional file 2: of Chart validation of an algorithm for identifying hereditary progressive muscular dystrophy in healthcare claims
167. Additional file 1: of Chart validation of an algorithm for identifying hereditary progressive muscular dystrophy in healthcare claims
168. 846853_Appendix_Table_1 – Supplemental material for Administrative claims data to support pragmatic clinical trial outcome ascertainment on cardiovascular health
169. Declining Public Health Burden of Digoxin Toxicity from 1991 to 2004: 041.
170. Use of Antiepileptic Drugs in Patients with Kidney Disease
171. Insider trading under rule 10b-5.
172. The Pharmacodynamic Characterization of an Antisense Oligonucleotide Against Monoamine Oxidase-B (MAO-B) in Rat Brain Striatal Tissue
173. Give good green light & red light
174. 812776_supp_mat – Supplemental material for FDA-Catalyst—Using FDA’s Sentinel Initiative for large-scale pragmatic randomized trials: Approach and lessons learned during the planning phase of the first trial
175. Characterization of Bariatric Surgery and Outcomes using Administrative Claims Data in the Research Network of a Nationwide Commercial Health Plan (Preprint)
176. Incidence of statin use in older adults with and without cardiovascular disease and diabetes mellitus, January 2008- March 2018
177. Capture of biologic and biosimilar dispensings in a consortium of U.S.‐based claims databases: Utilization of national drug codes and Healthcare Common Procedure Coding System modifiers in medical claims
178. Harnessing the Biologics and Biosimilars Collective Intelligence Consortium to Evaluate Patterns of Care
179. Advance Care Planning Claims and Health Care Utilization Among Seriously Ill Patients Near the End of Life
180. Descriptive Analysis of Long- and Intermediate-Acting Insulin and Key Safety Outcomes in Adults with Type 2 Diabetes Mellitus
181. Identification of potential drug name confusion errors in the Sentinel System
182. Antibiotic dispensing following pediatric visits in the US emergency departments and outpatient settings from 2006 to 2016
183. Administrative claims data to support pragmatic clinical trial outcome ascertainment on cardiovascular health
184. Data linkages between patient-powered research networks and health plans: a foundation for collaborative research
185. A new analytic tool developed to assess safe use recommendations
186. Mortality: The final outcome
187. The lowdown on the topless bar scene
188. Man in a skirt
189. Retained Laparotomy Sponges May Be Underreported
190. Capture of biologic and biosimilar dispensings in a consortium of U.S.‐based claims databases: Utilization of national drug codes and Healthcare Common Procedure Coding System modifiers in medical claims.
191. FDA-Catalyst—Using FDA’s Sentinel Initiative for large-scale pragmatic randomized trials: Approach and lessons learned during the planning phase of the first trial
192. Cancer Screening Results and Follow-up Using Routinely Collected Electronic Health Data: Estimates for Breast, Colon, and Cervical Cancer Screenings
193. Evaluating automated approaches to anaphylaxis case classification using unstructured data from the FDA Sentinel System
194. Early impact of the ICD-10-CM transition on selected health outcomes in 13 electronic health care databases in the United States
195. Diagnosis-based cohort augmentation using laboratory results data: The case of chronic kidney disease
196. A clinical prediction model to assess risk for pancreatic cancer among patients with pre-diabetes.
197. The man who mixed Adele's 'Hello': Grammy-winning sound engineer Tom Elmhirst has worked with everyone from Beck to Bowie--and believes big-time in the power of vinyl
198. Oral glucocorticoid use and osteonecrosis in children and adults with chronic inflammatory diseases: a population-based cohort study
199. Postauthorization safety study of the DPP-4 inhibitor saxagliptin: a large-scale multinational family of cohort studies of five outcomes
200. A clinical prediction model to assess risk for pancreatic cancer among patients with new-onset diabetes.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.